EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure

Xinyi Chen, Feiqiong Gao, Qiaoling Pan, Chenjie Huang, Rui Luo, Xiaoqing Lu, Xiaoxiao Chen, Tan Li, Haijun Huang iD, Jian Wu, Jiong Yu iD, Lanjuan Li iD und 1 weitere

Alimentary Pharmacology & Therapeutics · 2025-01 · 61 (2) · 286-298

DOI: 10.1111/apt.18347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.10.2024. Verfasst von Xinyi Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative…. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Research and Development Project of Zhejiang Province, High-level personnel cultivating project of Zhejiang Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early identification of hepatitis B virus‐related acute‐on‐chronic liver failure (HBV‐ACLF) holds crucial importance in guiding clinical management and reducing mortality. However, existing scoring systems often overlook patient's underlying clinical condition, which significantly impacts prognosis.

Aims

Use the age‐adjusted Charlson comorbidity index (aCCI) to evaluate the patient's complications to develop a more precise model for predicting transplant‐free mortality in HBV‐ACLF patients.

Methods

Nine hundred and six patients were included for investigation and were segregated into a training cohort and a temporal validation cohort according to the chronological order of admission in a ratio of 7:3. In the training cohort, univariate analysis, logistic regression analysis and LASSO regression analysis were used to construct a prognostic model and it was subsequently validated in a temporal validation cohort and an external validation cohort.

Results

We found total bilirubin, neutrophils, international normalised ratio and aCCI exhibited significant associations with 28‐day transplant‐free mortality and established a novel prognostic model, named aCCI‐HBV‐ACLF. The model demonstrated strong predictive performance, with area under the receiver operating characteristic curve (ROC) values of 0.859 for 28‐day mortality, 0.822 for 90‐day mortality. In the temporal validation cohort, aCCI‐HBV‐ACLF achieved area under the ROC values of 0.869 for 28‐day mortality and 0.850 for 90‐day mortality. In the external validation cohort, aCCI‐HBV‐ACLF had area under the ROC values of 0.868 for 28‐day mortality and 0.888 for 90‐day mortality.

Conclusions

This study proposes a new prognostic model, which achieved excellent predictive ability for 28−/90‐day transplant‐free mortality rates among patients with HBV‐ACLF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureHumansFemaleMaleMiddle AgedPrognosisAdultROC CurveHepatitis BComorbidityHepatitis B virusPredictive Value of TestsRetrospective StudiesAgedHepatitis B, Chronic

Stichwörter der Autor:innen

acute‐on‐chronic liver failureage‐adjusted Charlson comorbidity indexhepatitis Bprediction model

Autor:innen und Institutionen

  • State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,…
  • Department of Infectious Diseases, Zhejiang Provincial People's Hospital & People's Hospital Affiliated of Hangzhou Medical College, Hangzhou City, China.
  • National Medical Center for Infectious Diseases, Hangzhou City, China.
  • Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou City, China.
  • Zhejiang Key Laboratory for Diagnosis and Treatment of Physic-Chemical and Aging-Related Injuries, Hangzhou City, China.

ORCID-Profile: Haijun Huang, Jiong Yu, Lanjuan Li, Hongcui Cao

Förderung

  • Key Research and Development Project of Zhejiang Province
  • High-level personnel cultivating project of Zhejiang Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Chen, X., Gao, F., Pan, Q., Huang, C., Luo, R., Lu, X., Chen, X., Li, T., Huang, H., Wu, J., Yu, J., Li, L., & Cao, H. (2025). aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure. Alimentary Pharmacology & Therapeutics, 61(2), 286-298. https://doi.org/10.1111/apt.18347

Vancouver

Chen X, Gao F, Pan Q, Huang C, Luo R, Lu X, et al. aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure. Alimentary Pharmacology & Therapeutics. 2025;61(2):286-298. doi:10.1111/apt.18347

BibTeX
@article{Chen2025,
  author = {Chen, Xinyi and Gao, Feiqiong and Pan, Qiaoling and Huang, Chenjie and Luo, Rui and Lu, Xiaoqing and Chen, Xiaoxiao and Li, Tan and Huang, Haijun and Wu, Jian and Yu, Jiong and Li, Lanjuan and Cao, Hongcui},
  title = {aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {2},
  pages = {286--298},
  doi = {10.1111/apt.18347}
}
Kostenlos starten →